News
If you or someone you know has received a prostate cancer diagnosis, here's where to start, what to ask and how to plan ...
"I'm so lucky to have people in my life who didn't hightail it out," actor and three-time cancer survivor Colin Egglesfield tells PEOPLE.
Prostate cancer is the second most common cancer diagnosis in men. About one in eight men will be diagnosed with this disease during their lifetime. New Mexico Living spoke with Dr. Jose Avitia ...
An expert discusses how the PEACE III trial demonstrated that combining radium-223 with enzalutamide significantly improved ...
J&J has rights to niraparib in prostate cancer, and views the drug as a successor to Zytiga, once a $2.5 billion-a-year ...
2d
Clinical Trials Arena on MSNFDA and EMA authorise AB Science’s Phase III trial of prostate cancer treatmentThe FDA and the EMA have authorised AB Science’s confirmatory Phase III Study AB22007 trial of masitinib for mCRPC.
Irish Cancer Society data shows many women not getting an appointment within target timeframe of 10 working days ...
June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...
New insights gained with its help enable better risk assessment for affected families and could form the ... Precision Therapy for Metastatic Prostate Cancer Improves Survival; Wednesday ...
I’ve been part of a pilot study for a cancer survivors’ group called Create to Heal, meeting at the regional cancer hospital in Santa Fe. We recently ...
15d
E! News on MSNHusband and Wife Both Diagnosed With Stage 4 Cancer Within Same WeekKevin Wilson and Wendy Wilson, who have been married for 19 years and share four children, both received stage 4 cancer ...
An expert highlights that the future of metastatic castration-resistant prostate cancer (mCRPC) treatment is advancing with novel drug classes such as radioligand therapies, proteolysis-targeting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results